/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for METABASIS THERAPEUTICS INC (MBRX) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 0.31\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n 0.00\n\n (0.00%)\n\n \n\n \n\n \n\n \n\n Volume: 0\n\n \n\n \n\n\n\n 4:00 PM EST Jan 27, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
June 08,2009
\n \n
Close: \n 1.15\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
May 27,2009
\n \n
Close: \n 0.21\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
0.31
\n 		\n\n \n \n \n
Change $
\n \n \n \n
\n 		\n \n\n \n \n
Change %
\n\n \n \n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
N/A
\n 		\n \n \n \n\n
Bid Size
0
\n 		\n \n \n \n
Ask
N/A
\n\n 		\n \n \n \n
Ask Size
0
\n
\n \n \n \n
Open
N/A
\n 		\n \n \n \n
High
N/A
\n 		\n\n \n \n \n
Low
N/A
\n 		\n \n\n \n \n
Prev Close
0.31
\n
\n \n\n \n \n
Last Trade
1/27/10
\n 		\n \n \n \n
Volume
0
\n 		\n \n \n \n
\n
52 Wk Hi
1.15
\n 		\n\n \n \n \n
52 Wk Low
0.21
\n
\n \n\n \n \n
Market Cap
10.9 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
N/A
\n 		\n \n \n \n
Yield
N/A
\n\n
\n \n\n \n \n
Shares
35,157,359
\n 		\n \n \n \n
EPS (TTM)
-0.34
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
Nasdaq Small Caps (NSC)
\n
\n
\n
\n
\n
\n \n
Exchange
NSC
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for METABASIS THERAPEUTICS INC\n\n \n\n  (MBRX) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for MBRX\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jan 28, 2010
\n\n \n\n\n\n
9:00 AM\n\n\n\n Ligand Completes Acquisition of Metabasis - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Oct 29, 2009
\n\n \n\n\n\n
6:52 AM\n\n\n\n Trading Outlook for Metabasis Therapeutics Issued by StockPreacher.com - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Oct 27, 2009
\n\n \n\n\n\n
7:30 AM\n\n\n\n Metabasis Announces Ligand to Acquire Metabasis for Cash and Contingent Value Rights - Business Wire
7:30 AM\n\n\n\n Ligand to Acquire Metabasis for Cash and Contingent Value Rights - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Oct 20, 2009
\n\n \n\n\n\n
1:27 PM\n\n\n\n Burnham Institute for Medical Research Appoints First Chief Business Officer - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Sep 18, 2009
\n\n \n\n\n\n
4:30 PM\n\n\n\n Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Sep 10, 2009
\n\n \n\n\n\n
3:36 PM\n\n\n\n Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Sep 09, 2009
\n\n \n\n\n\n
4:30 PM\n\n\n\n Metabasis Therapeutics Receives Notice of Delisting from Nasdaq Capital Market - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jul 29, 2009
\n\n \n\n\n\n
6:55 AM\n\n\n\n Beacon Equity Issues Trading Outlook for Metabasis Therapeutics Inc. - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jun 01, 2009
\n\n \n\n\n\n
2:00 PM\n\n\n\n OTC Select Announces Nasdaq Stock Watch - World Stock Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Jun 10, 2008
\n\n \n\n\n\n
11:29 AM\n\n\n\n Pfizer completes $195 million Encysive acquisition and Metabasis Presents Preclinical Results for MB07803, Its Product Candidate for Type 2 Diabetes, and Its Glucagon Antagonist Program at the American Diabetes Association Meeting - US Equity News
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Apr 17, 2007
\n\n \n\n\n\n
1:52 PM\n\n\n\n Metabasis to Host Conference Call and Live Webcast to Discuss First Quarter 2007 Financial Results - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Apr 16, 2007
\n\n \n\n\n\n
4:00 PM\n\n\n\n Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Apr 12, 2007
\n\n \n\n\n\n
4:00 PM\n\n\n\n Metabasis Therapeutics Discusses Its Computer-Assisted Drug Design Technology - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Apr 04, 2007
\n\n \n\n\n\n
8:01 AM\n\n\n\n Metabasis Therapeutics Initiates a Proof of Concept Study for MB07803, Its Second Product Candidate for the Treatment of Type 2 Diabetes - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Mar 22, 2007
\n\n \n\n\n\n
4:24 PM\n\n\n\n Metabasis Therapeutics to Present Poster at American Association for Cancer Research - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Mar 15, 2007
\n\n \n\n\n\n
2:05 PM\n\n\n\n Metabasis to Present at BioCentury and Thomson Financial's 2007 Future Leaders in the Biotech Industry Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Mar 08, 2007
\n\n \n\n\n\n
4:00 PM\n\n\n\n Metabasis Therapeutics Reports on 2006 Financial Results and Business Accomplishments and Provides Guidance for 2007 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Mar 06, 2007
\n\n \n\n\n\n
7:52 PM\n\n\n\n Metabasis to Present at Cowen and Company Health Care Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Feb 22, 2007
\n\n \n\n\n\n
4:33 PM\n\n\n\n Metabasis to Present at Susquehanna Financial Group's 'SIGnificant Investment Options in Healthcare' Conference - PR Newswire
\n\n More News for MBRX >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");